However, in the early third trimester its presence is
espite advances in obstetrical and perinatal care during the past several decades, the rate of preterm birth has remained unchanged or has risen. 1, 2 Specifically, the extensive use of tocolytic agents has done little to reduce perinatal morbidity and mortality from preterm delivery. 3, 4 Despite its pivotal role in management, identification of patients at risk for preterm delivery is difficult. Current methods of detecting patients at risk for preterm delivery rely on obstetric history, demographic factors, or premonitory symptoms that are neither sensitive nor specific, s Biochemical markers were developed in the hope that they could predict which patients were destined to have a preterm delivery at an early enough interval such that the delivery could be avoided. Biochemical markers can be categorized into one of a number groups. The first group is the inflammatory mediators, or cytokines, which are produced during preterm labor in response to infection. Fetal fibronectin (FFN) is a glycoprotein produced by the fetus at the interface of the placenta and membranes with the uterine decidua during pregnancy. It can frequently be identified in the lower genital tract secretions in very early pregnancy or late pregnancy.
However, in the early third trimester its presence is Correspondence to: Dr. Steven R. Inglis 6 In the presence of intraamniotic infection, markedly elevated levels of inflammatory mediators, or cytokines, are seen in the amniotic fluid. The cytokines interleukin-l, interleukin-6, and tumor necrosis factor-or have all been measured in the amniotic fluid. The inflammatory mediators then stimulate prostaglandin synthesis by a variety of uterine tissues. The prostaglandins then lead to parturition. [1] [2] [3] Also, elevated cytokine levels in the amniotic fluid predict preterm labor that is refractory to tocolysis resulting in preterm delivery. 3 Elevated levels of cytokines measured non-invasively from the lower genital tract also predict preterm delivery. 4 The role of these putative virulence factors during pregnancy has not been studied in women. However, such microbe-produced substances (i.e., collagenase) along with similar enzymes produced of such virulence factors within the vagina may predispose to premature cervical ripening, preterm labor, or premature rupture of membranes. An association between virulence-factor presence and shortened cervical length or funneling would support these processes.
PROLACTIN
Prolactin is produced by the decidua, maternal adenohypophysis, and fetal pituitary. Decidual production of prolactin is induced by the alpha subunit of human chorionic gonadotropin. Prolactin is then diffused across the membranes to the amniotic cavity. The role of the prolactin is not clear, but it may suppress the synthesis of prostaglandins and augment fetal lung maturity. High levels of prolactin are found in the amniotic fluid during the second and third trimesters. Prolactin measured in the washings of the ectocervix and vaginal fornices predicts those patients likely to deliver at 34 weeks of gestation or before, as well as those with shorter latency to delivery and deliveries with lower birthweights, z9 The question of whether prolactin is actively produced and shed through the cervix or leaked subclinically through the fetal membranes remains unresolved. The initiation and extent of cytokine production in response to various stimuli is under genetic control and would be expected to vary between individuals. 43 None of the biochemical markers has turned out to be the "solution" to preterm delivery. Substantive improvements in our clinical management and outcome of preterm labor can only come with understanding of its pathophysiology. These markers allow us to objectively determine pathophysiology in at least some of the mothers who have a preterm delivery. Only through investigations of the bio-
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